News
In today’s enterprise environments, as cloud transformation and AI adoption are being operationalized, the operational continuity of engineers that understand the systems and have the ability to act ...
Definite, a full-stack artificial intelligence-native data platform, said it raised $10 million in seed funding led by venture capital firm Costanoa, with participation from Acrew Capital and ...
LONDON and SAN FRANCISCO, Aug. 26, 2025 /PRNewswire/ -- Attio, the AI-native CRM for the next era of companies, today announced it has raised $52 million in Series B funding. The round was led by GV ...
AUSTIN, Texas--(BUSINESS WIRE)-- CrowdStrike (CRWD) (NASDAQ: CRWD) today announced its intent to acquire Onum, a pioneer in real-time telemetry pipeline management. This acquisition evolves Falcon® ...
Megastar Chiranjeevi’s upcoming Telugu fantasy action film, Vishwambhara, has received a major update. Directed by Mallidi Vassishta and produced by UV Creations, the film also stars Trisha Krishnan, ...
Recently released Windows 11 24H2 updates are reportedly causing data corruption and failure issues for some SSD and HDD models on up-to-date systems. While some of the impacted drives were restored ...
The World Economic Outlook (WEO) database contains selected macroeconomic data series from the statistical appendix of the World Economic Outlook report, which presents the IMF staff's analysis and ...
Parallel file system legend Gary Grider, High Performance Computing Division Leader at Los Alamos National Lab, and Molly Presley, a well-known executive in the high performance storage sector and ...
The North American leg of the Oasis Live ‘25 tour kicked off in Toronto this weekend. Find out what went down at the show below. It was one of the rainiest gigs of the tour so far, with a constant ...
The IPO -- comprising fresh issuance of Rs 1,500 crore and an offer for sale (OFS) to the tune of Rs 579 crore -- was open for subscription from August 19 to August 21. According to provisional ...
Shares of Serina Therapeutics gained after the company said the Food and Drug Administration supports its trial design for an advanced Parkinson's treatment. The stock rose 28%, to $7.24, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results